Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.FDA approves generic allergy drug
Cetirizine hydrochloride is antihistamine drug, which is used to treat allergies, hives, and other allergic inflammatory conditions. These new products are bioequivalent to Zyrtec Allergy tablets and Zyrtec
Cetirizine hydrochloride is antihistamine drug, which is used to treat allergies, hives, and other allergic inflammatory conditions. These new products are bioequivalent to Zyrtec Allergy tablets and Zyrtec
Adolor and Pfizer are collaborating on the worldwide development and commercialization of two novel delta opioid agonist compounds, ADL5859 and ADL5747, for the treatment of pain. The delta
Argatroban is approved by the FDA for the treatment of heparin-induced thrombocytopenia. Encysive is the holder of the new drug application for Argatroban, and has licensed the North
The acquisition was completed in accordance with the merger agreement announced earlier among Plethico, Nutra Acquisition Company (MergerSub), a wholly owned subsidiary of Plethico, and Natrol, by means
Carolyn Logan, president and CEO, said: “Salix is committed to aggressively protecting its Colazal business and growing market share in the inflammatory bowel disease market. As part of
Mr. Mrha has been vice president of sales and marketing for IVX Animal Health, a member of the Teva Group, based in St. Joseph, Missouri. Marvin Sackner, CEO
MorphoSys plans to reveal the target molecule of its lead antibody program MOR103 and additional information on the design of the Phase I clinical study on January 16,
The first funding under the securities purchase agreement between Neoprobe and Montaur is for $7 million, which will be used to repay in full $5.7 million in notes
These payments were necessary in order for Elanco to secure commercialization rights to products for use in poultry and the right to potentially expand commercialization into other food
In this study, Duchenne muscular dystrophy (DMD) patients between 10 and 13 years of age received a single injection of PRO051 (a 2-’O-methyl antisense oligonucleotide) in a small